Clinical Trials

To take advantage of the UK's quick medication approval procedures, the North American psychedelic drug companies Mindset, PharmAla, Mydecine, and Psyence have inked a contract with the clinical research organisation (CRO) Clerkenwell Health to test treatments for mental health...

Immix Biopharma, Inc, a biopharmaceutical company pioneering Tissue-Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases, announced patient dosing in its ongoing Phase 1b/2a IMX-110 monotherapy clinical trial. This is the fifteenth patient dosed with IMX-110 to-date. IMX-110 clinical trial...

The growth in ongoing clinical trials for oligonucleotide-based therapies in important therapeutic fields like oncology is expected to cause the global oligonucleotide synthesis market to reach $16.7 billion by 2027 during the forecast timeframe, according to a recent market...

A multi-drug, precision medicine trial involving Roche, the University of Manchester, and Cancer Research UK has begun for patients with rare cancers who need additional treatment options. The DETERMINE study is one of the only platform trials using precision...

Clinical trials have expanded from 2,119 in 2000 to over 409,000 in 2022 (and counting). Not only has the number of trials increased, but so has the volume of data. Phase III clinical trials generate 3.6 million data points on...

Through its approach to NHS England, the non-profit organisation Kidney Cancer UK was able to gain funding for the National Institute for Health and Care Excellence (NICE) to create the first-ever clinical guidelines for the disease. The organisation conducted an...

A new ingestible sensor system that was put to the test in an interventional clinical trial gave HIV patients real-time antiretroviral dosage information, helping them to better manage their infection. The Proteus Digital Health Feedback (PDHF) information technology system kept...